Mesoblast Stock Price Prediction

MESO Stock  USD 11.03  0.92  9.10%   
The RSI of Mesoblast's the stock price is about 60. This indicates that the stock is rather overbought by investors as of today. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Mesoblast, making its price go up or down.

Oversold Vs Overbought

60

 
Oversold
 
Overbought
The successful prediction of Mesoblast's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Mesoblast, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Mesoblast's stock price prediction:
EPS Estimate Next Year
(0.78)
Wall Street Target Price
14.5
Quarterly Revenue Growth
(0.41)
Using Mesoblast hype-based prediction, you can estimate the value of Mesoblast from the perspective of Mesoblast response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Mesoblast to buy its stock at a price that has no basis in reality. In that case, they are not buying Mesoblast because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Mesoblast after-hype prediction price

    
  USD 9.68  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Mesoblast Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mesoblast's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
3.128.1213.12
Details
Naive
Forecast
LowNextHigh
5.3710.3715.37
Details
3 Analysts
Consensus
LowTargetHigh
6.226.837.58
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Mesoblast After-Hype Price Prediction Density Analysis

As far as predicting the price of Mesoblast at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mesoblast or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Mesoblast, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Mesoblast Estimiated After-Hype Price Volatility

In the context of predicting Mesoblast's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mesoblast's historical news coverage. Mesoblast's after-hype downside and upside margins for the prediction period are 4.68 and 14.68, respectively. We have considered Mesoblast's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
11.03
9.68
After-hype Price
14.68
Upside
Mesoblast is slightly risky at this time. Analysis and calculation of next after-hype price of Mesoblast is based on 3 months time horizon.

Mesoblast Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Mesoblast is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mesoblast backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mesoblast, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.00 
5.14
  0.51 
 0.00  
9 Events / Month
18 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
11.03
9.68
4.25 
1,008  
Notes

Mesoblast Hype Timeline

Mesoblast is now traded for 11.03. The entity has historical hype elasticity of -0.51, and average elasticity to hype of competition of 0.0. Mesoblast is projected to decline in value after the next headline, with the price expected to drop to 9.68. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -4.25%, whereas the daily expected return is now at 1.0%. The volatility of related hype on Mesoblast is about 205600.0%, with the expected price after the next announcement by competition of 11.03. The book value of the company was now reported as 0.42. The company recorded a loss per share of 1.05. Mesoblast had not issued any dividends in recent years. The entity had 1:2 split on the 10th of January 2024. Given the investment horizon of 90 days the next projected press release will be in about 9 days.
Check out Mesoblast Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.

Mesoblast Related Hype Analysis

Having access to credible news sources related to Mesoblast's direct competition is more important than ever and may enhance your ability to predict Mesoblast's future price movements. Getting to know how Mesoblast's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mesoblast may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
VIRIVirios Therapeutics Llc 0.14 5 per month 0.00 (0.06) 12.46 (10.62) 50.54 
ADTXAditxt Inc(0.12)9 per month 0.00 (0.64) 6.04 (28.15) 50.07 
LPCNLipocine 0.09 5 per month 3.75  0.10  7.08 (6.14) 27.84 
APGNApexigen(0.02)5 per month 5.50 (0) 7.89 (11.11) 58.79 
CNTBConnect Biopharma Holdings 0.02 5 per month 5.38  0.01  12.12 (9.01) 48.67 
ABOSAcumen Pharmaceuticals(0.10)4 per month 0.00 (0.06) 7.52 (6.67) 28.07 
ETONEton Pharmaceuticals(0.23)8 per month 1.77  0.36  7.56 (3.13) 21.89 
NUVBNuvation Bio 0.21 8 per month 4.59 (0) 9.48 (8.36) 21.30 
ELDNEledon Pharmaceuticals 0.17 5 per month 3.04  0.09  10.09 (4.24) 28.12 
LIANLianBio ADR 0.00 0 per month 3.34  0.01  6.76 (5.00) 20.98 
FENCFennec Pharmaceuticals(0.02)11 per month 3.83 (0.02) 7.14 (6.68) 23.48 
LRMRLarimar Therapeutics(0.49)9 per month 0.00 (0.06) 10.87 (9.55) 26.71 
VRCAVerrica Pharmaceuticals(0.07)8 per month 0.00 (0.13) 11.24 (12.50) 74.69 
FIXXHomology Medicines(0.01)2 per month 3.52  0.01  5.77 (5.61) 19.43 
XFORX4 Pharmaceuticals 0.02 7 per month 0.00 (0.08) 6.90 (10.61) 62.35 
INZYInozyme Pharma(0.03)8 per month 0.00 (0.27) 5.68 (7.92) 16.62 
TERNTerns Pharmaceuticals 0.30 8 per month 0.00 (0.09) 5.68 (5.96) 34.09 
DAWNDay One Biopharmaceuticals 0.23 9 per month 2.72 (0.04) 3.84 (3.69) 11.44 
HOOKHookipa Pharma 0.09 7 per month 0.00 (0.36) 4.05 (7.24) 22.98 
FBIOFortress Biotech(0.06)8 per month 0.00 (0.1) 7.43 (5.08) 26.13 
MBIOMustang Bio(0.02)4 per month 0.00 (0.14) 7.14 (8.70) 41.50 
ACHLAchilles Therapeutics PLC(0.03)4 per month 1.53  0.11  3.06 (2.88) 38.16 
APTOAptose Biosciences(0.01)7 per month 0.00 (0.20) 5.41 (7.69) 33.33 
FBIOPFortress Biotech Pref 0.00 0 per month 0.00 (0.15) 3.13 (4.72) 16.27 

Mesoblast Additional Predictive Modules

Most predictive techniques to examine Mesoblast price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mesoblast using various technical indicators. When you analyze Mesoblast charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Mesoblast Predictive Indicators

The successful prediction of Mesoblast stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Mesoblast, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Mesoblast based on analysis of Mesoblast hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Mesoblast's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Mesoblast's related companies.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding157.39110.751.3K1.2K
PTB Ratio0.521.061.371.3

Story Coverage note for Mesoblast

The number of cover stories for Mesoblast depends on current market conditions and Mesoblast's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mesoblast is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mesoblast's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Mesoblast Short Properties

Mesoblast's future price predictability will typically decrease when Mesoblast's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Mesoblast often depends not only on the future outlook of the potential Mesoblast's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mesoblast's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding98.7 M
Cash And Short Term Investments63 M
When determining whether Mesoblast offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesoblast's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesoblast Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesoblast Stock:
Check out Mesoblast Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesoblast. If investors know Mesoblast will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesoblast listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.05)
Revenue Per Share
0.06
Quarterly Revenue Growth
(0.41)
Return On Assets
(0.05)
Return On Equity
(0.18)
The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their own opinion of Mesoblast's value that differs from its market value or its book value, called intrinsic value, which is Mesoblast's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesoblast's market value can be influenced by many factors that don't directly affect Mesoblast's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.